On Invalid Date, Skye Bioscience (NASDAQ: SKYE) reported Q4 2023 earnings per share (EPS) of $1.01, up 125.63% year over year. Total Skye Bioscience earnings for the quarter were -$4.42 million. In the same quarter last year, Skye Bioscience's earnings per share (EPS) was -$3.94.
As of Q2 2024, Skye Bioscience's earnings has grown year over year. Skye Bioscience's earnings in the past year totalled -$37.64 million.
What is SKYE's earnings date?
Skye Bioscience's earnings date is Invalid Date. Add SKYE to your watchlist to be reminded of SKYE's next earnings announcement.
What was SKYE's revenue last quarter?
On Invalid Date, Skye Bioscience (NASDAQ: SKYE) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Skye Bioscience's revenue was $0.00.
What was SKYE's revenue growth in the past year?
As of Q2 2024, Skye Bioscience's revenue has grown null year over year. Skye Bioscience's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.